Teddi Mellencamp looked for advice while sharing she was “full of anxiety” amid her immunotherapy treatment. The Real ...

An enhanced version of an immunotherapy drug has shown significant promise against aggressive cancers in phase-1 trials, according to researchers ...

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that ...

Teddi's followers have her back. The post Teddi Mellencamp Experiencing ‘Severe Anxiety’ Amid Immunotherapy Treatment ...

A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer ...

The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...

Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the ...

Bain Capital, 65 Equity Partners, Arlington Capital Partners and Revelstoke Capital Partners are among the PE firms investing in the immunotherapy sector.

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

Selected patients with a clinical response after therapy could benefit from salvage surgery in non–small cell lung cancer (NSCLC), with acceptable results for perioperative morbidity.

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.